OPIOID EFFECTS AND OPIOID WITHDRAWAL DURING A 24 H DOSING INTERVAL IN PATIENTS MAINTAINED ON BUPRENORPHINE

Benzer Materyaller

• BUPRENORPHINE DOSING REGIME IN THE MANAGEMENT OF OUT-PATIENT HEROIN WITHDRAWAL
  Yazar:: LINTZERIS, N.
  Baskı/Yayın Bilgisi: (2002)
• PREDICTORS OF OUTCOME FOR SHORT-TERM MEDICALLY SUPERVISED OPIOID WITHDRAWAL DURING A RANDOMIZED, MULTICENTER TRIAL OF BUPRENORPHINE-NALOXONE AND CLONIDINE IN THE NIDA CLINICAL TRIALS NETWORK DRUG AND ALCOHOL DEPENDENCE
  Yazar:: ZIEDONIS, D.M
  Baskı/Yayın Bilgisi: (2009)
• OPIOID DETOXIFICATION USING HIGH DOSES OF BUPRENORPHINE IN 24 HOURS: A RANDOMIZED, DOUBLE BLIND, CONTROLLED CLINICAL TRIAL
  Yazar:: ASSADI, S.M
  Baskı/Yayın Bilgisi: (2004)
• THE USE OF INTRAVENOUS BUPRENORPHINE FOR THE TREATMENT OF OPIOID WITHDRAWAL IN MEDICALLY ILL HOSPITALIZED PATIENTS
  Yazar:: WELSH, C.J
  Baskı/Yayın Bilgisi: (2002)
• BUPRENORPHINE DOSING REGIME FOR INPATIENT HEROIN WITHDRAWAL: A SYMPTOM-TRIGGERED DOSE TITRATION STUDY
  Yazar:: LINTZERIS, N.
  Baskı/Yayın Bilgisi: (2003)